US Stock MarketDetailed Quotes
ABBV AbbVie
- 183.080
- +1.940+1.07%
Close Nov 27 16:00 ET
- 183.080
- 0.0000.00%
Post 20:01 ET
323.53BMarket Cap63.79P/E (TTM)
184.240High180.890Low5.27MVolume181.140Open181.140Pre Close966.03MTurnover0.30%Turnover Ratio67.31P/E (Static)1.77BShares207.32052wk High53.64P/B322.59BFloat Cap137.62452wk Low6.13Dividend TTM1.76BShs Float207.320Historical High3.35%Div YieldTTM1.85%Amplitude20.016Historical Low183.255Avg Price1Lot Size
About AbbVie Company
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Company Profile
SymbolABBV
Company NameAbbVie
Listing DateDec 10, 2012
Founded2011
CEOMr. Robert A. Michael
MarketNYSE
Employees50000
Fiscal Year Ends12-31
Address1 North Waukegan Road
CityNorth Chicago
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-847-932-7900
Websitehttp://www.abbvie.com
Company Executives
- Name
- Position
- Salary
- Robert A. Michael
- Director and Chief Executive Officer
- 14.44M
- Timothy J. Richmond
- Executive Vice President and Chief Human Resources Officer
- --
- Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD
- Executive Vice President and Chief Operations Officer
- 9.30M
- Jeffrey Ryan Stewart
- Executive Vice President and Chief Commercial Officer
- 15.35M
- Dr. Thomas J. Hudson, M.D.
- Senior Vice President and Chief Scientific Officer, Global Research
- --
- Scott Reents
- Executive Vice President and Chief Financial Officer
- 10.19M
- Dr. Nicholas Donoghoe
- Executive Vice President, Chief Business and Strategy Officer
- --
- Dr. Roopal Thakkar, M.D.
- Senior Vice President and Chief Medical Officer, Global Therapeutics
- --
- Kevin K. Buckbee
- Senior Vice President, Controller and Principal Accounting Officer
- --
- Perry C. Siatis
- Executive Vice President, General Counsel and Secretary
- --
- Richard A. Gonzalez
- Chairman of the Board
- 25.66M
- Glenn F. Tilton
- Lead Independent Director
- 421.58K
- Dr. Susan E. Quaggin, M.D.
- Independent Director
- 24.00K
- Roxanne S. Austin
- Independent Director
- 388.39K
- Rebecca B. Roberts
- Independent Director
- 359.98K
- Dr. Robert J. Alpern,M.D.
- Independent Director
- 461.18K
- Frederick H. Waddell
- Independent Director
- 369.98K
- Brett J. Hart
- Independent Director
- 384.98K
- Melody B. Meyer
- Independent Director
- 369.98K
- Jennifer L. Davis
- Independent Director
- 45.00K
- William H.L. Burnside
- Independent Director
- 377.48K
- Thomas C. Freyman
- Independent Director
- 389.98K
- Edward J. Rapp
- Independent Director
- 394.98K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data